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Purpose: This study aimed to investigate the breast dose reduction potential of a breast-positioning
(BP) technique for thoracic CT examinations with organ-based tube current modulation (OTCM).
Methods: This study included 13 female anthropomorphic computational phantoms (XCAT, age
range: 27–65 y.o., weight range: 52–105.8 kg). Each phantom was modified to simulate three breast
sizes in standard supine geometry. The modeled breasts were then morphed to emulate BP that con-
strained the majority of the breast tissue inside the 120° anterior tube current (mA) reduction zone.
The OTCM mA value was modeled using a ray-tracing program, which reduced the mA to 20% in
the anterior region with a corresponding increase to the posterior region. The organ doses were esti-
mated by a validated Monte Carlo program for a typical clinical CT system (SOMATOM Definition
Flash, Siemens Healthcare). The simulated organ doses and organ doses normalized by CTDIvol were
used to compare three CT protocols: attenuation-based tube current modulation (ATCM), OTCM,
and OTCM with BP (OTCMBP).
Results: On average, compared to ATCM, OTCM reduced breast dose by 19.3  4.5%, whereas
OTCMBP reduced breast dose by 38.6  8.1% (an additional 23.8  9.4%). The dose saving of
OTCMBP was more significant for larger breasts (on average 33, 38, and 44% reduction for 0.5, 1,
and 2 kg breasts, respectively). Compared to ATCM, OTCMBP also reduced thymus and heart dose
by 15.1  7.4% and 15.9  6.2% respectively.
Conclusions: In thoracic CT examinations, OTCM with a breast-positioning technique can markedly
reduce unnecessary exposure to radiosensitive organs in anterior chest wall, specifically breast tissue.
The breast dose reduction is more notable for women with larger breasts. © 2016 American Associa-
tion of Physicists in Medicine [https://doi.org/10.1002/mp.12076]
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1. INTRODUCTION
Computed tomography (CT) has significantly benefitted the
clinical diagnosis of a wide spectrum of diseases. In the past
decades, the use of CT has grown exponentially. In 2014,
approximately 81.2 million CT examinations were performed
in the United States.1,2 The increased number of CT examina-
tions has led to concerns about the associated population-
based radiation dose.3 Significant efforts have been made to
minimize unnecessary radiation exposure and maximize
patient benefits through the development of dose reduction
techniques.4 These techniques generally aim to reduce the
unnecessary exposure to major radiosensitive organs while
maintaining the required image quality level.5,6
Breasts are among the most radiosensitive organs for
female patients.7,8 In thoracic CT examinations, although
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breasts are usually not diagnostically targeted, they receive a
considerable amount of radiation dose.9–12 In an effort to pro-
tect superficial radiosensitive organs such as breasts, some
vendors have developed organ-based tube current modulation
(OTCM) techniques.13 In one implementation of OTCM, the
tube current (mA) is reduced by 80% in the anterior region
( 60°) of the patient with a corresponding increase in the
posterior region (X-CARE, Siemens Healthcare). It has been
reported that, with OTCM, breast doses can be reduced by
30–50% with no detrimental effect on image quality.5,6,14
However, a major challenge associated with the OTCM tech-
nique has been the extension of the breasts being outside the
dose reduction zone.15 A previous study has shown that,
without any constraint, when the patient is supine, the breast
tissue extends within an average angular zone of 155°; this is
larger than the 120° dose reduction zone angle.16 In effect,
for most women, at least one breast partly resides in the
increased dose zone, between  75° and  84°.17 Another
challenge with OTCM and associated breast dose is that the
outer breast region contains a higher percentage of glandular
tissue, making it more susceptible to cancer.18 Majority of
breast malignant tumors first develop in the upper outer quad-
rant of the breast.19 As a result, the effectiveness of OTCM
has been questioned, especially for women with larger
breasts.15
The purpose of this study was to evaluate the dose reduc-
tion potential of a specially designed breast-positioning tech-
nique for OTCM examinations. The breast-positioning
technique was modeled by constraining most of the breast tis-
sue to within the dose reduction zone. The dose reduction
potential of this technique was evaluated across a library of
phantoms with various ages, weights, and breast sizes. The
organ doses were computed from Monte Carlo simulations
with three CT scan protocols: attenuation-based tube current
modulation (ATCM), OTCM, and OTCM with breast posi-
tioning altered (referred to as OTCMBP).
2. MATERIALS AND METHODS
2.A. Computational phantoms
This study included models of 13 female adult patients
(age range: 27–65 y.o., weight range: 52–105.8 kg) who
received a chest and abdominal-pelvis, or a chest-abdominal-
pelvis CT examination at our institution. The patients repre-
sented anatomical variability among clinical population with
a broad range of age and BMI distribution (Fig. 1).
The models have been developed from the CT images of
the patients.20 Initially, large organs within the scan volumes
were segmented to generate phantom masks followed by 3D-
triangulated polygon models using a marching cubes algo-
rithm. The polygon structure was translated to 3D
nonuniform rational B-spline surface (NURBS) (Rhinoceros,
McNeel North America, Seattle, WA). The remaining organs
and structures were generated by morphing a template’s cor-
responding anatomies. The template was segmented from
high-resolution visible human female full-body images.21,22
The organ volume was rescaled to the organ volume and
anthropometry data reported in ICRP 89.23 The phantoms
frontal views are shown in Fig. 2. Each phantom was vox-
elized at an isotropic resolution of 3.45 mm for input into a
Monte Carlo simulation program. The resolution was chosen
considering the anatomic details and simulation time.24
To investigate the effect of dose on glandular density, two
compositions of breasts were simulated: (1) 50/50 breast
(50% glandular tissue and 50% adipose tissue), as a represen-
tative case for younger women and (2) 20/80 breast (20% of
glandular tissue and 80% adipose tissue), which was an
approximation of mean glandular percentage in a wide popu-
lation.25–27
2.B. Morphing the breasts
The phantom library was enhanced by modeling each
phantom with three breast sizes (Fig. 3). To allow for the use
of additional breast sizes, the torso surface of each phantom
was first modeled as a smooth breast-free surface. The indi-
vidual breasts were modeled as closed surfaces that were
added to the breast-free surface. This modeling provided a
library of 39 phantoms with the preserved breast-free surface
and kept all other organs and structures constant.
Breast positioning (BP) was simulated on each phantom.
The BP effectively modeled a support brassiere, which
pressed breast tissue closer to the center of the torso to a
greater extent than a normal brassiere. This ensured a major-
ity of breast tissue within the  60° dose reduction zone. In
order to facilitate the morphing, finite element models of the
breasts were created.28 A voxelized version of each breast (at
isotropic resolution of 0.2 mm) was used to create hexahedral
finite elements for each voxel. The elements adjacent to the
midline of the torso or the imaginary breast-free torso surface
were constrained to have zero displacement. This restricted
the overall motion of the breast and provided a consistent
FIG. 1. BMI and age distribution of the computational phantoms. [Color
figure can be viewed at wileyonlinelibrary.com]
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attachment to the remainder of the body during the deforma-
tion. The breasts were modeled as a uniform hyperelastic
Neo-Hookean material with a moduli of elasticity (E_adi-
pose 1 kPa), which has been previously used for breast FE
simulations,29–31 and a nearly incompressible Poisson’s
ratio of 0.49. The deformation due to the BP support was
approximated as a body force roughly tangential to the
breast-free torso surface, where the magnitude of the body
force was scaled to achieve the desired positioning. The
resulting large deformation finite element model was solved
using FEBio (University of Utah’s Musculoskeletal
Research Laboratories and Columbia’s Musculoskeletal
Biomechanics Laboratory).32 The force was applied incre-
mentally using 20 equal steps to account for the large
deformations.
Deformation fields from the finite element analysis were
applied to transform the polygon meshes and subsequently
NURBS surfaces of each breast. Manual corrections were
applied, when necessary, to further morph the breasts to
ensure that the desired positioning was achieved and that the
breast volume remained constant. Figure 3 shows an example
phantom with three breast sizes before and after applying BP.
The phantom library was further divided into three groups by
breast size: small (447  187 g), medium (1068  222 g),
and large-sized (1929  432 g) groups. The percentage of
breast volume within dose reduction zone in standard supine
positioning and after applying BP is listed in Table I.
2.C. CT examination simulations
A previously validated Monte Carlo simulation program
was used to simulate CT scans.27,33 The package included
PENOLOPE as a subprogram to track the energy loss of
photons.34,35
A 64-section CT system (SOMATOM Definition Flash;
Siemens Healthcare, Forchheim, Germany) was modeled.36
The scan parameters were 120 kVp, pitch factor of 0.6, rota-
tion time of 0.5 s, table speed of 2.304 cm/rot, 38.4 mm col-
limation, quality reference mAs of 150 mAs, and CTDIvol
value denoted in Section 2.D. Clinical CT exams with ATCM
FIG. 2. 3D frontal view of the phantoms. [Color figure can be viewed at wileyonlinelibrary.com]
FIG. 3. Transverse slice of a modified voxelized XCAT phantom.
Three breast sizes are shown: (a) small, (b) medium (c) large with breasts in
standard supine position (left column) and the corresponding slice with
breast-positioning technique (right column). The breast tissue is highlighted
with light color. [Color figure can be viewed at wileyonlinelibrary.com]
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were simulated for each standard supine phantom and OTCM
simulated for all phantoms. The scan coverage was defined as
1 cm above lung apex to 1 cm below lung base.
The attenuation-based tube current modulation profile
(mAATCM) simulated the virtual CAREDose4D, which takes
into account attenuation of patient in both longitudinal (Z)
and angular (XY) plane.37 The XYZ attenuation through the
phantom was simulated by a previously developed ray-tracing
program.24 At each projection angle h, the ‘fanbeam’ func-
tion was used to measure the line integrals of attenuation
coefficients alone each ray from the source to each detector
bin (Matlab2010a; Mathworks, Natick, MA). The maximum
line integrals of attenuation coefficients (ud) from all detector
bins at h was selected as the basis to generate tube current
profile at h. The tube current profile was modeled as
mAATCM hð Þ ¼ mA0  eaud hð Þ; (1)
where mA0 and mAATCM hð Þ are the fixed and attenuation-based
modulated mA, respectively, ud(h) is the maximum line inte-
grals of attenuation coefficients calculated at h, and a is the
modulation strength.38 A typical averaged modulation strength
level (a = 0.5) was used. Finally, at each rotation, the tube cur-
rent was scaled to below the systems’ maximum mA limit.
To generate the organ-based tube current profile (mAOTCM)
(X-CARE, Siemens Healthcare), the longitudinal (Z-plane)
profile was reduced by 80% between  60° and the reduction
was evenly divided and added to the remaining projections
within one rotation. The angular (XY-plane) modulation was
turned off.13 The longitudinal-profile was modeled as




where mA0 and mAZ hð Þ are the fixed and longitudinal modu-
lated mA respectively, ud hAPð Þ and ud hLATð Þ are the attenua-
tion in AP (anterior–posterior) and in LAT (lateral) direction
along the Z-plane at gantry angle h.24 This approach emu-
lated the CT system, in that the Z-profile was generated prior
to the scan based on localization radiographs in LAT and AP
directions.24 The simulation further modeled gradual change
in mA (slope as a function of rotation time, and upward- and
downward-transition time) when switching between mA
reduction and mA increase zone. Using 0.28 rot/s and 1 rot/s
per Duan et al.,13 the mA upward and downward times at
0.5 rot/s were estimated using linear approximation as 17%
and 6% of rotation time respectively. The mA value was gen-
erated for models without and with BP separately, thus,
referred to as mAOTCM and mAOTCM,BP, respectively. The
mAATCM, mAOTCM, and mAOTCM,BP of one example phan-
tom is shown in Fig. 4.
2.D. Organ dose estimation
Organ doses were determined by tracking the energy
deposited within each organ using flux for a particular
CTDIvol value specific to each phantom as dictated by the
average mA over the scan coverage of the applied TCM. The
CTDIvol values for the phantoms scanned with OTCM and
ATCM ranged from 4.7 to 16.2 mGy. With breast position-
ing, CTDIvol changed slightly by an average of 4  5%
reduction leading to a CTDIvol range of 4.5–17.1 mGy. The
Size-Specific Dose Estimate (SSDE) was also calculated for
each simulated scan using each phantom’s chest water equiv-
alent diameter39 and the SSDE/CTDIvol conversion factors as
defined by AAPM task group 204.40 To report in detail, the
CTDIvol and SSDE values for ATCM/OTCM and OTCMBP
were fitted as an exponential function of chest water-equiva-
lent diameters (Fig. 5). For CTIDvol, the fitting equations
were CTDIvol;ATCM=OTCM ¼ 0:56e0:09d and CTDIvol;OTCMBP ¼
0:49e0:1d for ATCM/OTCM and OTCMBP, respectively,
where d represents chest water-equivalent diameter. For
SSDE, the fitting equations were SSDEATCM=OTCM ¼
2:12e0:06d and SSDEOTCMBP ¼ 1:94e0:06d for ATCM/OTCM
and OTCMBP, respectively. All fittings have R2  0:9.
The organ doses were further normalized by CTDIvol to
derive the CTDIvol-to-organ dose conversion coefficients (h
factors). As CTDIvol alone significantly influences dose,
expanding the results in terms of h factors could be inter-
preted as a comparing technique where total flux (and thus
image quality by implication) remains constant, so that the
net effect of modulation alone on dose can be evaluated by
comparing hATCM and hOTCM . Similarly, the net effect of
breast positioning alone can be evaluated by comparing
hOTCM and hOTCM;BP. The breast dose was computed for both
50/50 and 20/80 homogeneous breasts.
The organ dose and h factors’ percentage difference for
breasts as well as other organs were calculated for OTCM,
OTCMBP, and ATCM, respectively. Organs were further
grouped into anterior organs, medial or distributed organs,
and posterior organs based on organ geometric center loca-
tions with respect to the isocenter of CT scanner.
Because breast positioning repositions more breast volume
within the dose reduction zone for larger breasts (Table I), in
order to assess the effect of breast mass on dose reduction
potential, the breast dose value and h factors were further fit-
ted to breast mass as
D̂breast ¼ pD;1mbreast þ pD;2 (3a)
ĥbreast ¼ ph;1mbreast þ ph;2; (3b)
where D̂breast and ĥbreast denote the fitted breast dose and
h factors for breasts, respectively, mbreast is the weight of
both breasts in each phantom, and p1 and p2 are the lin-
ear fitting coefficients.
TABLE I. Mean of percentage of breast volume from all phantoms within
 60° frontal zone with and without breast positioning (BP).
Without BP (%) With BP (%) Change in Volume (%)
Small breasts 68.5  11.1 93.9  4.2 25.5  12.1
Medium breasts 68.0  17.0 93.7  5.2 25.6  14.3
Large breasts 57.2  14.5 93.9  3.3 36.6  12.3
All Models 64.6  15.2 93.8  4.0 29.1  14.1
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To better estimate the overall organ dose reduction poten-
tial for OTCM and OTCMBP, the average effective dose was
calculated for ATCM, OTCM, and OTCMBP. The effective
dose was calculated as the sum of organ doses multiplied by
tissue weighting factors defined by ICRP 103,41 following the
common practice of using effective dose as the scalar metric
of radiation dose, even though, by definition, the effective
dose can only be evaluated by reference phantoms. The doses
for organs not explicitly modeled (salivary glands-, extratho-
racic (ET) region-, oral mucosa-doses, lymphatic nodes-, and
muscle-doses), were approximated by the doses to neighbor-
ing organs.33
In order to report the organ dose, an exponential regres-
sion model of h factors and chest diameter was calculated as
ĥ ¼ eahdþbh ; (4)
where ĥ denotes the fitted h factors, ah and bh are the fit-
ting coefficients, and d is the chest diameter. Thus, given
the patient size and CTDIvol the organ dose can be rapidly
predicted for this specific tube current modulation scheme
and CT scanner.36,37,42,43 Please note that this organ dose
estimation technique is more accurate for organs within
the scan coverage, where the majority of the dose is
distributed.38
3. RESULTS
On average, compared to ATCM, OTCM reduced the 50/
50 breast dose by 19.3  4.5%. The average breast dose was
further decreased by an additional 23.8  9.4% to
38.6  8.1% with OTCMBP compared to ATCM (Fig. 6).
The corresponding percentage reduction in terms of h factors
were 21.3  7.3% (OTCMBP to OTCM) and 36.5  6.9%
(OTCMBP to ATCM), respectively. Table II shows the aver-
age breast dose and h factors for the 50/50 and 20/80 breasts
simulated with ATCM, OTCM, and OTCMBP. The difference
in h factors between the two breast compositions was
8.8  0.5%, and the two compositions exhibited very similar
FIG. 4. An example of the tube current profile generated for attenuation-based tube current modulation (ATCM), organ-based tube current modulation (OTCM),
and OTCM with breast positioning (OTCMBP) for a phantom with breast mass of 1098 g (50/50 breast). The shaded regions correspond to the dose reduction
zone. [Color figure can be viewed at wileyonlinelibrary.com]
FIG. 5. (a) CTDIvol and (b) SSDE values for ATCM/OTCM and OTCMBP scans fitted to chest water-equivalent diameter. [Color figure can be viewed at
wileyonlinelibrary.com]
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trends in terms of impact of imaging method on dose. Fig-
ure 7 shows dose distribution plots of one phantom with
small, medium, and large breasts undergoing ATCM, OTCM,
and OTCMBP exams at a mid-transverse plane.
The breast dose saving of OTCMBP compared to ATCM
was more significant for patients with larger breasts. For
small (447  187 g), medium (1068  222 g), and large-
sized (1929  432 g) groups, OTCMBP and ATCM breast
dose difference were 32.6  7.0%, 38.3  5.2%, and
44.8  7.2%. The corresponding values in terms of h fac-
tors difference were 31.4  6.5%, 36.8  5.0%, and
41.3  5.3%, respectively (Table III). Compared to OTCM
alone, OTCMBP breast dose decreased by 18.7  9.0%,
22.3  7.1%, and 30.5  8.2% for small-, medium-, and
large-sized groups, respectively. The corresponding value in
terms of h factors were 17.3  7.8%, 20.4  6.2%, and
26.2  4.9%. The fitting coefficients of dose values vs. breast
mass for the three protocols are given inTable IV (Fig. 8).
Figure 9 shows the organ dose differences between
OTCMBP and ATCM, OTCM and ATCM, and OTCMBP and
OTCM. Compared to ATCM, OTCM significantly reduced
dose and h factors to general anterior organs (except larynx–
pharynx) ( p\0:01). Doses to several organs (large intestine,
stomach, thymus, pancreases, and small intestine) decreased
up to 10%. The doses to medial and posterior organ dose in
OTCM compared to ATCM was increased by less than 10%
( p\0:01). For distributed organs such as bone marrow and
bone surface, which are located more toward posterior of the
patient, organ doses were increased by ~10%. The skin dose
remained relatively constant. When using BP compared to
OTCM alone, all organ doses were decreased or not changed
significantly. The corresponding h factors to anterior organs
were decreased or not changed significantly and the h factors
to medial and posterior organs were increased by less than
3% (except for spleen).
Table V shows the average effective dose results for 39
phantoms and different breast-sized groups. The results
showed that the effective doses were similar for ATCM and
OTCM with 4.8  1.1 mSv and 4.6  1.0 mSv, respec-
tively. ATCM to OTCM effective dose reduction was ~6%
for all breast-size groups. With BP, the average effective dose
was reduced to 4.2  1.0 mSv. Compared to ATCM,
OTCMBP reduced effective dose by 11.2  3.0%,
12.4  3.6%, and 15.2  6.0% for small-, medium-, and
large-sized breast groups, respectively.
Figure 10 shows h factors fitted to patient chest diameter
as an exponential function and Table VI shows the fitting
coefficients. For organs within the scan coverage (lung,
esophagus, heart, thymus, trachea-bronchi), the organ doses
were more strongly correlated with chest diameters
ðR2 [ 0:7Þ, except for breasts. For distributed organs, the cor-
relations were moderate ð0:85[R2 [ 0:6Þ. For organs on
the periphery or outside of the scan coverage, the correlations
were relatively small R2  0:6 .
FIG. 6. (a) Breast dose and (b) average of CTDIvol-normalized-breast breast dose coefficients simulated with ATCM, OTCM, and OTCMBP for all phantoms
with 50/50 and 20/80 breasts. Error bars represent  1 standard deviation. [Color figure can be viewed at wileyonlinelibrary.com]
TABLE II. Average breast dose and the difference from ATCM, OTCM, and OTCMBP.
a
Breast dose






50/50 9.9  2.9 7.9  2.1 6.0  1.7 38.6  8.1b 19.3  4.5b 23.8  9.4b
20/80 9.0  2.6 7.2  1.9 5.5  1.6 38.1  8.1b 19.2  4.5b 23.4  9.3b
CTDIvol-normalized breast dose coefficients












50/50 1.0  0.1 0.8  0.1 0.7  0.1 36.5  6.9b 19.3  4.5b 21.3  7.3b
20/80 0.9  0.1 0.8  0.1 0.6  0.1 36.0  6.8b 19.2  4.5b 20.8  7.2b
aNegative means dose reduction.
brepresents statistical significant.
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4. DISCUSSION
Organ-based tube current modulation techniques have
been devised to minimize unnecessary radiation exposure to
major radiosensitive organs while maintaining the required
image quality. In this work, we evaluated the dose saving
potential of an additional breast-positioning technique for
organ-based tube current modulation examinations (OTCM).
Compared to standard tube current modulation, OTCM
offered an average of 19.3  4.5% reduction in breast dose.
The breast positioning extended that reduction by an additive
23.8  9.4%. Targeted breast positioning takes a fuller
advantage of OTCM for reducing breast dose in body CT
examinations.
In this study, a constant CTDIvol value was used for
ATCM and OTCM scheme for each phantom. A previous
study has argued that OTCM is less dose-economical com-
pared to ATCM, and resulted in a 5–10% CTDIvol increase to
maintain image quality.14 When OTCM is utilized, the x-y
modulation is shut off, the Z-plane mA is generated based on
FIG. 7. Dose distribution plots of one example phantom with small (a), medium (b), and large (c) breasts. [Color figure can be viewed at wileyonlinelibrary.com]
TABLE III. Average breast dose coefficients and dose difference in different sized breast group.a
Breast dose






Small 8.0  2.5 6.5  1.8 5.4  1.9 32.6  7.0b 16.9  4.1b 18.7  9.0b
Medium 9.3  2.2 7.4  1.6 5.8  1.4 38.3  5.2b 20.5  4.3b 22.3  7.1b
Large 12.4  2.1 9.8  1.5 6.8  1.4 44.8  7.2b 20.6  4.3b 30.5  8.2b
CTDIvol-normalized breast dose coefficients












Small 1.1  0.1 0.9  0.1 0.7  0.1 31.4  6.5b 16.9  4.1b 17.3  7.8b
Medium 1.0  0.1 0.8  0.1 0.6  0.1 36.8  5.0b 20.5  4.3b 20.4  6.2b
Large 1.0  0.1 0.8  0.1 0.6  0.1 41.3  5.3b 20.6  4.3b 26.2  4.9b
aNegative means dose reduction.
brepresents statistical significant.
TABLE IV. Fitting coefficients of breast dose and CTDIvol-normalized breast





1ð Þ pD;2 RMSE ph;1 kg1ð Þ ph;2 RMSE
ATCM 2.7 6.58 2.18 0.007 1.042 0.073
OTCM 1.99 5.45 1.57 0.027 0.87 0.098
OTCMBP 0.94 4.83 1.57 0.063 0.735 0.084
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FIG. 8. (a) breast dose and (b) CTDIvol-normalized breast dose coefficients linearly fitted to breast mass scanned with ATCM, OTCM, and OTCMBP as Eq (2).
[Color figure can be viewed at wileyonlinelibrary.com]
FIG. 9. Differences in (a) organ dose and (b) CTDIvol-normalized organ dose coefficients across ATCM, OTCM, and OTCMBP. [Color figure can be viewed at
wileyonlinelibrary.com]
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the average of AP and LAT attenuation. If techniques permit,
keeping x-y plane modulation in OTCM would be more dose
efficient. We simulated this scenario (OTCMideal), reducing
mAATCM by 80% and a corresponding increase in the remain-
ing projections. The dose reduction was larger in anterior
organs. The dose for heart and thymus was reduced by
14.7  3.4% and 20.0  4.6%, respectively. The dose
increase was smaller in distributed and posterior organs (ex-
cept for spleen). No significant change was noted in lung,
esophagus, and kidneys.
To take full advantage of OTCM, breast-positioning tech-
niques have been studied to constrain the breast to within the
dose reduction zone. Seidenfuss et al. have demonstrated that
a normal brassiere can constrain more breast tissue within the
dose reduction zone.44 However, in that implementation, the
breasts are still not fully sheltered, especially in women with
larger breasts where only 83.3% of the volume is constrained.
Additionally, the study did not evaluate the breast dose. In
this study, we simulated the breast-positioning technique that
can optimize breast position beyond a normal brassiere’s sup-
port by compressing more breast tissue to within the dose
reduction zone. To ensure the modeled breast locations
reflect real scenario, the percentage of breast tissue within the
dose reduction zone was compared with those reported in lit-
erature. Seidenfuss et al. reported breast volumes within dose
reduction zone on CT images from 578 female patients with
and without brassiere.44 On average, 60.4  24.7% and
91.3  9.4% of breast volume was within dose reduction
zone without and with a brassiere, respectively.44 In our
work, the average breast tissue within the dose reduction zone
was 64.6  15.2% originally, and increased to 93.8  4.0%
after applying BP. The ratio of breast within the dose reduc-
tion zone is higher in this study compared to Seidenfuss et al.
because the breast tissue was compressed closer toward the
center of the torso. To implement the studied breast-position-
ing technique clinically, we recommend the use of sports
brassiere with foam padding.
The breast dose savings of OTCM and OTCMBP from
ATCM were compared with physical phantoms reported by
literature. Comparing OTCM to ATCM reduction for an
anthropomorphic phantom with breast attachment, Lungren
et al. reported the anterior and posterior breast dose reduction
of 29–45% and 9–19%, respectively.16 Our results were gener-
ally consistent; from ATCM to OTCM, the average breast
dose reduction ranges at 11.0–28.7%. For ATCM to OTCMBP,
the breast dose reduction ranges at 21.0–51.8% and when nor-
malized by CTDIvol, the corresponding reduction ranges at
20.6%–48.1%. Another study reported that breast dose was
reduced by 34%, 34%, and 39% with OTCM compared to
ATCM for small, medium, and large semi-anthropomorphic
phantoms (30 9 20, 35 9 25, 4 9 30 cm in lateral and pos-
terior–anterior dimension).14 To derive breast dose corre-
sponding to the above average chest diameter in our study, the
breast dose was fitted to chest diameter as an exponential
function [Eq. (4)] (Fig. 11). On average, compared to ATCM,
OTCM reduced breast dose by 13.1%, 18.1%, and 22.8%, and
h factors by 12.7%, 18.0%, and 23.0%. The OTCM savings in
our study was smaller compared to the literature, as the XCAT
breasts were explicitly modeled, while the phantoms used in
other studies were with “underdeveloped” breasts (i.e., the
breasts were not spread).6,13,14,16,45 Thus, more lateral portions
of the XCAT breasts were in the dose-increased zone. The full
advantage of OTCM was not taken without BP. The OTCMBP
saved the breast dose by 34.4%, 38.1%, 41.5% and h factors
by 30.1%, 35.3%, and 40.2% for phantoms with 25 cm,
30 cm, and 35 cm chest diameters, respectively.
Using the same CTDIvol, OTCM reduced the effective
dose, this can be explained by the fact that most of the
radiosensitive organs are located anteriorly.46 Lungren et al.
reported the effective dose by evaluating the organ dose
recorded by dosimeters for an anthropomorphic physical
phantom. The results were 4.41  0.3 mSv (after scanning
CTDIvol 6.94 mGy) and 5.25  0.36 mSv (after scanning
CTDIvol 7.51 mGy) for ATCM and OTCM, respectively.
16
TABLE V. Average effective dose and the difference between ATCM, OTCM, and OTCMBP.
a
Effective dose (ED)






Small 4.2  1.1 3.9  0.97 3.7  1.0 11.2  3.0b 5.6  1.7b 5.9  4.1b
Medium 4.7  0.88 4.5  0.81 4.2  0.87 12.4  3.6b 5.8  1.9b 7.0  4.2b
Large 5.6  0.77 5.3  0.71 4.8  0.78 15.2  6.0b 5.5  1.4b 10.3  6.4b
All models 4.8  1.1 4.6  1.0 4.2  1.0 12.9  4.6b 5.6  1.7b 7.7  5.2b
ED normalized by dose-length-product (DLP)












Small 0.022  0.002 0.021  0.002 0.020  0.001 9.8  2.0b 5.6  1.7b 4.4  2.6b
Medium 0.021  0.002 0.020  0.002 0.019  0.002 10.3  3.8b 5.8  1.9b 4.8  3.3b
Large 0.020  0.002 0.019  0.002 0.018  0.002 9.7  2.3b 5.5  1.4b 4.5  1.6b
All models 0.021  0.002 0.020  0.002 0.019  0.002 9.9  2.7b 5.6  1.7b 4.6  2.5b
aNegative means dose reduction.
brepresents statistical significant change.
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The discrepancy between Lungren et al. and this study can
be explained by the fact that the CTDIvol used in this study
was constant between OTCM and ATCM, while the CTDIvol
for OTCM is generally 5–10% higher as noted previously.
Other organ doses were also compared with physical
phantoms. Lungren et al. has reported anterior organ dose
reduced 17–47%; posterior organ dose significantly
increased; lateral and inner organ dose showed similar
results.16 Our results were consistent on some typical anterior
and posterior organs. Thymus and kidney dose changed by
10.5% and 1.6% (7% and 1% from Lungren et al.). The
skin dose profile was also compared with measurement of
physical phantoms from the literature. The skin dose was
sampled and interpolated within 360 degrees for each phan-
tom on one selected slice that contains large volume of breast
tissue. The interpolated skin dose was further averaged across
all phantoms. Duan et al. reported surface dose of anthropo-
morphic phantoms receiving OTCM and fixed mA scan
(mAfix).
13 To compare our results to those of Duan et al., the
skin dose was normalized by CTDIvol and scaled to unit
FIG. 10. The CTDIvol-normalized organ dose coefficients fitted against phantom chest diameters as shown in Eq (4). Example organs from (a–c) anterior, (d,e)
medial or distributed, and (f) posterior groups. [Color figure can be viewed at wileyonlinelibrary.com]
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average. Our results showed excellent agreement with the
measurement from physical phantoms (Fig. 12). For OTCM,
the dose was unsymmetrical on the left and right reduction
zone, which was due to unequal upward- and downward-tran-
sition times. Compared to mAfix, the mAATCM is generally
larger in LAT and smaller in AP.
Although the use of a patient’s own brassiere is cost effi-
cient, a specially designed BP support would be superior as it
compresses more of the breast tissue within the dose reduc-
tion zone, especially the outer quadrant of the breast, which
more than half of breast carcinoma first occurs.18,19,47 With a
normal brassiere, 17% of the breast is outside the dose
FIG. 11. (a) Breast dose and (b) CTDIvol-normalized breast dose from ATCM, OTCM, and OTCMBP simulations fitted to chest diameter as Eq (4). [Color figure
can be viewed at wileyonlinelibrary.com]
TABLE VI. Fitting parameters of CTDIvol-
normalized organ dose coefficients (h factors)
with respect to chest diameter [Eq. (4)].
ATCM OTCM OTCMBP
Organ ah;ATCM bh;ATCM R
2 ah;OTCM bh;OTCM R
2 ah;OTCM;BP bh;OTCM;BP R
2
Anterior organs
Breast 0.01 0.47 0.45 0.03 0.65 0.56 0.03 0.51 0.47
Large intestine 0.04 3.43 0.12 0.03 3.44 0.10 0.04 3.71 0.15
Stomach 0.05 1.05 0.31 0.05 0.96 0.30 0.04 0.44 0.20
Liver 0.03 0.36 0.46 0.03 0.25 0.38 0.02 0.12 0.28
Thyroid 0.08 1.85 0.53 0.07 1.51 0.53 0.05 0.85 0.41
Larynx–pharynx 0.01 1.09 0.09 0.01 1.18 0.06 0.00 1.51 0.00
Trach-bronchi 0.06 1.89 0.94 0.05 1.65 0.92 0.05 1.53 0.86
Eyes 0.01 4.55 0.09 0.00 4.39 0.01 0.02 4.82 0.16
Thymus 0.06 1.90 0.89 0.06 1.73 0.89 0.05 1.37 0.75
Gallbladder 0.01 2.17 0.02 0.01 2.16 0.01 0.01 2.26 0.02
Heart 0.05 1.43 0.86 0.05 1.33 0.82 0.04 1.00 0.71
Pancreas 0.03 0.32 0.09 0.03 0.45 0.09 0.02 0.78 0.04
Small intestine 0.03 3.26 0.08 0.03 3.24 0.06 0.03 3.51 0.11
Bladder 0.01 5.76 0.02 0.01 5.83 0.02 0.01 5.88 0.01
Medial or distributed organs
Lung 0.04 1.35 0.87 0.04 1.26 0.84 0.04 1.25 0.81
Bone marrow 0.05 0.59 0.77 0.05 0.53 0.72 0.05 0.61 0.71
Esophagus 0.06 1.69 0.94 0.05 1.46 0.88 0.05 1.41 0.84
Bone surface 0.05 0.88 0.81 0.04 0.83 0.77 0.04 0.88 0.76
Skin 0.04 0.47 0.63 0.04 0.46 0.65 0.04 0.39 0.70
Brain 0.01 4.13 0.06 0.01 4.11 0.04 0.01 4.18 0.03
Posterior organs
Kidneys 0.11 1.54 0.48 0.11 1.58 0.46 0.11 1.71 0.46
Adrenals 0.10 2.21 0.55 0.10 2.48 0.54 0.11 2.78 0.54
Spleen 0.05 0.99 0.40 0.04 0.83 0.29 0.03 0.64 0.22
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reduction zone for large-sized breasts.44 With the imple-
mented BP, the portion of breast tissue within the dose-
increased zone decreases to 6%. Furthermore, BP constrains
an average constant portion (94%) of breast tissue within the
dose reduction zone in all groups. However, normal
brassiere’s performance varies among different breast-size
groups.44 The dose savings effect and potential artifacts in
CT images with various normal brassieres is yet to be exam-
ined. A standardized BP allows one to accurately monitor
dose and prospectively optimize CT procedure.
For all the organs within the scan coverage, lungs have
the same radiosensitivity as breasts.41 Our results showed
that lung dose only increased slightly using OTCM, com-
pared to ATCM. As the tube current was decreased anteri-
orly and increased posteriorly, the lung dose is non-
uniformly distributed. To estimate the distribution of lung
dose, lung dose was estimated at five different lung ROIs on
the dose distribution plot located as shown in Fig. 13. The
lung dose was averaged over each ROI across 39 phantoms
for each modulation scheme. The results showed that ante-
rior lung regions and posterior lung regions have lower and
higher dose, respectively, for OTCM, compared to ATCM.
For lung regions in the central line of AP direction, the lung
doses are similar for OTCM and ATCM. Lungren et al.
reported that the lung dose decreased by 7% (average of 12%
and 2%) and 13% (average of 18% and 7%) for anterior and
posterior lung regions, respectively.16 In their study, the
decrease of lung dose in posterior regions may be a result of
sampling posterior lung dose more centrally compared to our
sampling scheme.
FIG. 12. Skin dose simulated with computerized phantom with ATCM and
OTCM from this study compared skin dose measured with physical phan-
toms with OTCM and fixed mA from Duan et al. The dose was averaged to
a unit mean for comparisons. For this study, the skin dose profile was aver-
aged across all phantoms. The dose reduction zone is shaded. [Color figure
can be viewed at wileyonlinelibrary.com]
FIG. 13. (a) Example of five ROIs drawn on dose distribution plots to evaluate the non-uniform distribution of lung dose. (b) For each ROI, the average dose
value was calculated. [Color figure can be viewed at wileyonlinelibrary.com]
FIG. 14. (a) average glandular dose (AGD) and (b) CTDIvol-normalized-AGD simulated by OTCMBP vs. OTCM. The AGD was derived by Eq. (5). [Color figure
can be viewed at wileyonlinelibrary.com]
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In this study, the primary focus was breast dose. However,
the most relevant component of breast dose is average glan-
dular dose (AGD). A side study was conducted to ascertain
how the two are related. A prior study has derived the AGD
from homogeneous breast tissue via simulation.48 For each
photon–material interaction, the dose to breast tissue was cor-
rected to the glandular tissue by the ratio of glandular to
breast mass attenuation coefficients at that energy level.48
Using this approach, a conversion was derived as
rbreasttoAGD ¼
X l
q Ei; glandularð Þ
l
q Ei; breastð Þ
P Eið Þ; (5)
where P Eið Þ is source energy spectrum, filtered by the bowtie
filter, and lq Ei; glandularð Þ and lq Ei; breastð Þ are the mass
attenuation coefficients for glandular and breast tissues at
energy Ei, respectively. Assuming the spectrum’s further fil-
tering by patient body can be ignored, rbreasttoAGD was
computed to be 1.015 and 1.031 for the 50/50 breast and 20/
80 breast, respectively. This indicates the breast dose and
ADG are closely correlated at CT energies. Figure 14 shows
a plot of average glandular dose for OTCMBP vs. OTCM.
Please note, homogeneous distribution of glandular dose is
an approximation. Future study is warranted to simulate
heterogeneous breast tissue.
This work has several limitations. First, the dose coeffi-
cient estimation was limited to one CT scanner. Second,
although the dose reduction potential was demonstrated, an
optimized positioning technique with minimum dose and
patient comfort is yet to be defined. For each phantom, only
one breast positioning was simulated. Third, image quality
was not examined in this study. In previous studies, no signif-
icant difference in noise and CT numbers have been reported
when comparing OTCM with ATCM or fixed mA scans
using physical phantoms.13,14,16 Neither were streaking and
beam hardening artifacts with perceivable differences found.
In the work by Seidenfuss et al., the image quality was
assessed for women scanned with OTCM, with and without a
normal brassiere; no artifacts were reported.44 A similar
study will be conducted for OTCMBP in the future. Fourth,
the mA profile was generated theoretically, as the actual mA
in a CT system may not be predicted merely by patient atten-
uation.24 For example, the mA profile may overshoot at the
beginning of a scan.49 To ensure the tube current profile in
general agrees with the physical behavior, the skin dose was
sampled and compared to studies measuring skin dose on
physical phantoms and our results showed strong agreement
(Fig. 12). Future studies may include modeling the mA pro-
file taking into account actual physical behaviors. Fifth, the h
factors and the comparisons for different modulation schemes
reported in this study was specific to the mA scheme (average
modulation strength). The study of other modulation
strengths as well as other organ-based tube current modula-
tion schemes used by various scanners and the associated
effect on organ doses would be of value. However, as CTDIvol
is a strong normalizing and a major factor significantly influ-
encing organ dose, the CTDIvol-normalized organ dose
dataset can reasonably characterize the net effect of modula-
tion or breast positioning.
5. CONCLUSION
In this study, the dose reduction potential of alternate
breast positioning was evaluated for organ-based TCM exam-
inations. Keeping CTDIvol constant, on average, compared to
ATCM, OTCM reduced the breast dose by ~20%. The aver-
age breast dose was further decreased by an additional 23%
with targeted breast positioning. Targeted breast positioning
is needed to take full advantage of OTCM for reducing breast
dose in body CT examinations.
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